Suleiman Massarweh
- Oncology top 1%
- Molecular Biology top 5%
- Genetics top 1%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Rachel SchiffC. Kent OsborneJiang ShouHelen A. WeissSimak AliJianzhong ShouA. E. WakelingC. K. Osborne
- Topics
- HER2/EGFR in Cancer Research (22 papers)Estrogen and related hormone effects (17 papers)Breast Cancer Treatment Studies (16 papers)
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- New England Journal of MedicineJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesJordanSwitzerland
In The Last Decade
Suleiman Massarweh
45 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 2.1k
- Molecular Biology 1.7k
- Genetics 1.5k
- Cancer Research 877
- Pulmonary and Respiratory Medicine 694
Countries citing papers authored by Suleiman Massarweh
This map shows the geographic impact of Suleiman Massarweh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suleiman Massarweh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suleiman Massarweh more than expected).
Fields of papers citing papers by Suleiman Massarweh
This network shows the impact of papers produced by Suleiman Massarweh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suleiman Massarweh. The network helps show where Suleiman Massarweh may publish in the future.
Co-authorship network of co-authors of Suleiman Massarweh
This figure shows the co-authorship network connecting the top 25 collaborators of Suleiman Massarweh. A scholar is included among the top collaborators of Suleiman Massarweh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suleiman Massarweh. Suleiman Massarweh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 19 | |
| 3 | 31 | |
| 4 | 6 | |
| 5 | 21 | |
| 6 | 11 | |
| 7 | 48 | |
| 8 | 13 | |
| 9 | 11 | |
| 10 | 3 | |
| 11 | 28 | |
| 12 | 27 | |
| 13 | 66 | |
| 14 | 375 | |
| 15 | 101 | |
| 16 | 127 | |
| 17 | 33 | |
| 18 | 372 | |
| 19 | Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. | 250 |
| 20 | 15 |
About Suleiman Massarweh
Suleiman Massarweh is a scholar working on Oncology, Cancer Research and Toxicology, having authored 46 papers that have together received 3.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (22 papers), Estrogen and related hormone effects (17 papers) and Breast Cancer Treatment Studies (16 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (877 citations) and Genetics (1.5k citations). Suleiman Massarweh has collaborated with scholars based in United States, Jordan and Switzerland. Frequent co-authors include Rachel Schiff, C. Kent Osborne, Jiang Shou, Helen A. Weiss, Simak Ali, Jianzhong Shou, A. E. Wakeling, C. K. Osborne, Lavina Bharwani and Mothaffar F. Rimawi. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.